Strategies for immortalization of primary hepatocytes.

The liver has the unique capacity to regenerate in response to a damaging event. Liver regeneration is hereby largely driven by hepatocyte proliferation, which in turn relies on cell cycling. The hepatocyte cell cycle is a complex process that is tightly regulated by several well-established mechanisms. In vitro, isolated hepatocytes do not longer retain this proliferative capacity. However, in vitro cell growth can be boosted by immortalization of hepatocytes. Well-defined immortalization genes can be artificially overexpressed in hepatocytes or the cells can be conditionally immortalized leading to controlled cell proliferation. This paper discusses the current immortalization techniques and provides a state-of-the-art overview of the actually available immortalized hepatocyte-derived cell lines and their applications.

[1]  N. Kobayashi,et al.  Controlled Expansion of Mammalian Cell Populations by Reversible Immortalization , 2013 .

[2]  G. Michalopoulos,et al.  Population expansion, clonal growth, and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF, EGF and TGF alpha in a chemically defined (HGM) medium , 1996, The Journal of cell biology.

[3]  E. Andreakos,et al.  Activation of signalling pathways during hepatocyte isolation: relevance to toxicology in vitro. , 2004, Toxicology in vitro : an international journal published in association with BIBRA.

[4]  N. Shinomiya,et al.  Growth-related signaling regulates activation of telomerase in regenerating hepatocytes. , 2002, Experimental cell research.

[5]  C. Guguen-Guillouzo,et al.  The coculture: A system for studying the regulation of liver differentiation/proliferation activity and its control , 1997, Cell Biology and Toxicology.

[6]  P. Morel,et al.  Highly efficient lentiviral vector-mediated transduction of nondividing, fully reimplantable primary hepatocytes. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[7]  P. Bosma,et al.  Long-term amelioration of bilirubin glucuronidation defect in Gunn rats by transplanting genetically modified immortalized autologous hepatocytes. , 1998, Cell transplantation.

[8]  K. Vermeulen,et al.  The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer , 2003, Cell proliferation.

[9]  Dagmar Wirth,et al.  Transcriptional control of SV40 T-antigen expression allows a complete reversion of immortalization. , 2004, Nucleic acids research.

[10]  D. Trono,et al.  Treatment of acetaminophen-induced acute liver failure in the mouse with conditionally immortalized human hepatocytes. , 2005, Journal of hepatology.

[11]  M. Collins,et al.  Growth factors improve gene expression after lentiviral transduction in human adult and fetal hepatocytes , 2007, The journal of gene medicine.

[12]  N. Kobayashi,et al.  Establishment of a highly differentiated immortalized adult human hepatocyte cell line by retroviral gene transfer. , 2000, Transplantation proceedings.

[13]  Hayley S. Brown,et al.  Primary Hepatocytes: Current Understanding of the Regulation of Metabolic Enzymes and Transporter Proteins, and Pharmaceutical Practice for the Use of Hepatocytes in Metabolism, Enzyme Induction, Transporter, Clearance, and Hepatotoxicity Studies , 2007, Drug metabolism reviews.

[14]  J. Kantor,et al.  Establishment of a human neonatal hepatocyte cell line , 2009, In Vitro Cellular & Developmental Biology - Animal.

[15]  N. Fausto,et al.  New concepts in liver regeneration , 2011, Journal of gastroenterology and hepatology.

[16]  N. Chowdhury,et al.  Transplantation of conditionally immortalized hepatocytes to treat hepatic encephalopathy. , 1996, Hepatology.

[17]  K A Schafer,et al.  The Cell Cycle: A Review , 1998, Veterinary pathology.

[18]  M. Sakaguchi,et al.  Establishment of a human hepatocyte line (OUMS-29) having CYP 1A1 and 1A2 activities from fetal liver tissue by transfection of SV40 LT , 2001, In Vitro Cellular & Developmental Biology - Animal.

[19]  T. Seki,et al.  Role of p16INK4a in the inhibition of DNA synthesis stimulated by HGF or EGF in primary cultured rat hepatocytes , 2013 .

[20]  R. DePinho,et al.  Prolonged activation of the mitogen-activated protein kinase pathway promotes DNA synthesis in primary hepatocytes from p21Cip-1/WAF1-null mice, but not in hepatocytes from p16INK4a-null mice. , 1998, The Biochemical journal.

[21]  K. Kaestner,et al.  Distinct proliferative and transcriptional effects of the D-type cyclins in vivo , 2008, Cell cycle.

[22]  S. Strom,et al.  Preservation of hepatic phenotype in lentiviral-transduced primary human hepatocytes. , 2008, Chemico-biological interactions.

[23]  B. Fleshler,et al.  The Liver: Biology and Pathobiology , 1983 .

[24]  A. Pfeifer,et al.  Simian virus 40 large tumor antigen-immortalized normal human liver epithelial cells express hepatocyte characteristics and metabolize chemical carcinogens. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[25]  M. Manns,et al.  Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis , 2002 .

[26]  T. Kiyono,et al.  CDK4 and cyclin D1 allow human myogenic cells to recapture growth property without compromising differentiation potential , 2011, Gene Therapy.

[27]  M. Zern,et al.  Telomerase reconstitution immortalizes human fetal hepatocytes without disrupting their differentiation potential. , 2003, Gastroenterology.

[28]  L. Hayflick THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. , 1965, Experimental cell research.

[29]  S. Todo,et al.  Establishment of immortalized human hepatocytes by introduction of HPV16 E6/E7 and hTERT as cell sources for liver cell-based therapy. , 2008, Cell transplantation.

[30]  H. Hauser,et al.  Eternity and functionality – rational access to physiologically relevant cell lines , 2013, Biological chemistry.

[31]  Thomas M van Gulik,et al.  Evaluation of a new immortalized human fetal liver cell line (cBAL111) for application in bioartificial liver. , 2008, Journal of hepatology.

[32]  G. Michalopoulos,et al.  Epidermal growth factor- and hepatocyte growth factor-receptor activity in serum-free cultures of human hepatocytes. , 1999, Journal of hepatology.

[33]  John J Tyson,et al.  A model for restriction point control of the mammalian cell cycle. , 2004, Journal of theoretical biology.

[34]  C. Harris,et al.  Genomic instability and telomerase activity in human bronchial epithelial cells during immortalization by human papillomavirus-16 E6 and E7 genes. , 1997, Experimental cell research.

[35]  N. Kobayashi,et al.  Xenotransplantation of immortalized human hepatocytes for experimental acute liver failure in rats. , 2000, Transplantation proceedings.

[36]  M. Berry,et al.  The Hepatocyte Review , 2000, Springer Netherlands.

[37]  Li-Huei Tsai,et al.  Cyclin-dependent kinases: a family portrait , 2009, Nature Cell Biology.

[38]  Kimi Yamakoshi,et al.  The p16INK4a-RB pathway: molecular link between cellular senescence and tumor suppression. , 2004, The journal of medical investigation : JMI.

[39]  J. Mclean Immortalization Strategies for Mammalian Cells , 1999 .

[40]  H. Odagiri,et al.  A new method to immortalize primary cultured rat hepatocytes , 2004 .

[41]  L. S. Cram,et al.  SV40 T antigen alone drives karyotype instability that precedes neoplastic transformation of human diploid fibroblasts , 1990, Journal of cellular biochemistry.

[42]  W. Mok,et al.  Molecular and functional characterization of drug-metabolizing enzymes and transporter expression in the novel spontaneously immortalized human hepatocyte line HC-04. , 2007, Toxicology in vitro : an international journal published in association with BIBRA.

[43]  A. Józkowicz,et al.  Gene therapy on demand: site specific regulation of gene therapy. , 2013, Gene.

[44]  M. Grompe,et al.  Serial transplantation reveals the stem-cell-like regenerative potential of adult mouse hepatocytes. , 1997, The American journal of pathology.

[45]  David Mangnall,et al.  The molecular physiology of liver regeneration following partial hepatectomy , 2003, Liver international : official journal of the International Association for the Study of the Liver.

[46]  J. Albrecht,et al.  Transient expression of cyclin D1 is sufficient to promote hepatocyte replication and liver growth in vivo. , 2001, Cancer research.

[47]  F. Lottspeich,et al.  Tumor Necrosis Factor α Inhibits Oxidative Phosphorylation through Tyrosine Phosphorylation at Subunit I of Cytochrome c Oxidase* , 2008, Journal of Biological Chemistry.

[48]  M. Ouellette,et al.  Use of exogenous hTERT to immortalize primary human cells , 2004, Cytotechnology.

[49]  W. Oh,et al.  Mitogen-independent DNA synthesis by fetal rat hepatocytes in primary culture. , 1993, Experimental cell research.

[50]  P. Loyer,et al.  Regulation of the G1/S Transition in Hepatocytes: Involvement of the Cyclin-Dependent Kinase Cdk1 in the DNA Replication , 2012, International journal of hepatology.

[51]  André Guillouzo,et al.  EXPRESSION OF CYTOCHROMES P450, CONJUGATING ENZYMES AND NUCLEAR RECEPTORS IN HUMAN HEPATOMA HepaRG CELLS , 2006, Drug Metabolism and Disposition.

[52]  K. Meyer,et al.  Hepatitis C virus core protein is necessary for the maintenance of immortalized human hepatocytes. , 2002, Virology.

[53]  K. Jemnitz,et al.  Comparison of Human Hepatoma HepaRG Cells with Human and Rat Hepatocytes in Uptake Transport Assays in Order to Predict a Risk of Drug Induced Hepatotoxicity , 2013, PloS one.

[54]  C. Guguen-Guillouzo,et al.  Growth factor dependence of progression through G1 and S phases of adult rat hepatocytes in vitro. Evidence of a mitogen restriction point in mid-late G1. , 1996, The Journal of biological chemistry.

[55]  P. Gruppuso,et al.  D-type cyclins and G1 progression during liver development in the rat. , 2005, Biochemical and biophysical research communications.

[56]  C. Lang,et al.  Nuclear factor-kappaB mediates the inhibitory effects of tumor necrosis factor-alpha on growth hormone-inducible gene expression in liver. , 2008, Endocrinology.

[57]  Aarati R. Ranade,et al.  Robust expansion of human hepatocytes in Fah−/−/Rag2−/−/Il2rg−/− mice , 2007, Nature Biotechnology.

[58]  H. Malhi,et al.  The application of a lentiviral vector for gene transfer in fetal human hepatocytes , 2000, The journal of gene medicine.

[59]  Y. Wang,et al.  Transplantation of immortalized human fetal hepatocytes prevents acute liver failure in 90% hepatectomized mice. , 2010, Transplantation proceedings.

[60]  M. Schilsky,et al.  Conditional immortalization of gunn rat hepatocytes: An ex vivo model for evaluating methods for bilirubin‐UDP‐glucuronosyltransferase gene transfer , 1995, Hepatology.

[61]  David Durantel,et al.  The HepaRG cell line: biological properties and relevance as a tool for cell biology, drug metabolism, and virology studies. , 2010, Methods in molecular biology.

[62]  M. Sinz,et al.  Stem cells, immortalized cells and primary cells in ADMET assays. , 2006, Drug discovery today. Technologies.

[63]  K. Chayama,et al.  Establishment of functional telomerase immortalized human hepatocytes and a hepatic stellate cell line for telomere‐targeting anticancer drug development , 2010, Cancer science.

[64]  J. Lehmann,et al.  Cultivation of immortalized human hepatocytes HepZ on macroporous CultiSpher G microcarriers. , 2000, Biotechnology and bioengineering.

[65]  S. Kyo,et al.  Successful immortalization of endometrial glandular cells with normal structural and functional characteristics. , 2003, The American journal of pathology.

[66]  Chuang Lu,et al.  Enzyme inhibition in drug discovery and development : the good and the bad , 2010 .

[67]  S. Cascio Novel strategies for immortalization of human hepatocytes. , 2001, Artificial organs.

[68]  J. Shay,et al.  Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions. , 2001, Genes & development.

[69]  Hyunyoung Jeong,et al.  Characterization of increased drug metabolism activity in dimethyl sulfoxide (DMSO)-treated Huh7 hepatoma cells , 2009, Xenobiotica; the fate of foreign compounds in biological systems.

[70]  C B Harley,et al.  Replicative Senescence and Cell Immortality: The Role of Telomeres and Telomerase , 1997, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[71]  D. Peeper,et al.  The essence of senescence. , 2010, Genes & development.

[72]  N. Kobayashi,et al.  Role of immortalized hepatocyte transplantation in acute liver failure. , 2001, Transplantation proceedings.

[73]  C. Woodworth,et al.  Transformation of rat hepatocytes by transfection with simian virus 40 DNA to yield proliferating differentiated cells. , 1986, Cancer research.

[74]  Y. Nimura,et al.  Change in telomerase activity of rat organs during growth and aging. , 1998, Experimental cell research.

[75]  Jean S. Campbell,et al.  Liver regeneration. , 2012, Journal of hepatology.

[76]  C. Macdonald,et al.  The immortalisation of rat hepatocytes by transfection with SV40 sequences , 2004, Cytotechnology.

[77]  R. Ray,et al.  ISG56 and IFITM1 Proteins Inhibit Hepatitis C Virus Replication , 2011, Journal of Virology.

[78]  D. P. Sarkar,et al.  Ex vivo gene transfer into hepatocytes. , 2009, Methods in molecular biology.

[79]  J. Sahi,et al.  Induction of Drug Metabolism Enzymes and MDR1 Using a Novel Human Hepatocyte Cell Line , 2004, Journal of Pharmacology and Experimental Therapeutics.

[80]  C. Woodworth,et al.  Tumorigenicity of simian virus 40-hepatocyte cell lines: effect of in vitro and in vivo passage on expression of liver-specific genes and oncogenes , 1988, Molecular and cellular biology.

[81]  M. Bock,et al.  Epidermal growth factor improves lentivirus vector gene transfer into primary mouse hepatocytes , 2011, Gene Therapy.

[82]  S. Hirohashi,et al.  Cell lines from non-neoplastic liver and hepatocellular carcinoma tissue from a single patient , 1996, In Vitro Cellular & Developmental Biology - Animal.

[83]  P. Dent,et al.  The mitogen-activated protein (MAP) kinase cascade can either stimulate or inhibit DNA synthesis in primary cultures of rat hepatocytes depending upon whether its activation is acute/phasic or chronic. , 1998, The Biochemical journal.

[84]  Miran Kim,et al.  Loss of exon 4 in a human T‐cell factor‐4 isoform promotes hepatic tumourigenicity , 2013, Liver international : official journal of the International Association for the Study of the Liver.

[85]  C D Woodworth,et al.  Regulation of albumin gene expression in a series of rat hepatocyte cell lines immortalized by simian virus 40 and maintained in chemically defined medium , 1987, Molecular and cellular biology.

[86]  M. Sakaguchi,et al.  Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes. , 2000, Science.

[87]  C. Rescan,et al.  The Mitogen-Activated Protein Kinase Kinase/Extracellular Signal-Regulated Kinase Cascade Activation Is a Key Signalling Pathway Involved in the Regulation of G1 Phase Progression in Proliferating Hepatocytes , 1999, Molecular and Cellular Biology.

[88]  M. Müller,et al.  Immortalized human hepatocytes as a tool for the study of hepatocytic (de-)differentiation , 1997, Cell Biology and Toxicology.

[89]  G. Siest,et al.  Expression and regulation of drug metabolizing enzymes in an immortalized rat hepatocyte cell line. , 1991, Biochemical pharmacology.

[90]  Shi-Gui Yang,et al.  In Vitro Large-Scale Cultivation and Evaluation of Microencapsulated Immortalized Human Hepatocytes (HepLL) in Roller Bottles , 2009, The International journal of artificial organs.

[91]  S. Bacchetti,et al.  Chromosomal damage induced by human adenovirus type 12 requires expression of the E1B 55-kilodalton viral protein , 1990, Journal of virology.

[92]  A. F. Stewart,et al.  Precise conditional immortalization of mouse cells using tetracycline‐regulated SV40 large T‐antigen , 2010, Genesis.

[93]  M. Sakaguchi,et al.  Establishment of immortalized human hepatic stellate scavenger cells to develop bioartificial livers1 , 2003, Transplantation.

[94]  S. Dong,et al.  Survival of conditionally immortalized hepatocytes in the spleen of syngeneic rats , 2001, Journal of gastroenterology and hepatology.

[95]  M. Ozturk,et al.  Senescence and immortality in hepatocellular carcinoma. , 2009, Cancer letters.

[96]  Kousuke Saito,et al.  Microarray analyses and molecular profiling of Stat3 signaling pathway induced by hepatitis C virus core protein in human hepatocytes. , 2006, Virology.

[97]  R. Ray,et al.  Hepatitis C Virus Infection Impairs IRF-7 Translocation and Alpha Interferon Synthesis in Immortalized Human Hepatocytes , 2010, Journal of Virology.

[98]  André Guillouzo,et al.  The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics. , 2007, Chemico-biological interactions.

[99]  Troglitazone — a novel antidiabetic drug for treating insulin resistance , 1998 .

[100]  J. Shay,et al.  Bypass of telomere-dependent replicative senescence (M1) upon overexpression of Cdk4 in normal human epithelial cells , 2003, Oncogene.

[101]  B. Lindeman,et al.  CDK2 regulation through PI3K and CDK4 is necessary for cell cycle progression of primary rat hepatocytes , 2007, Cell proliferation.

[102]  Lan-juan Li,et al.  Advances in cell sources of hepatocytes for bioartificial liver. , 2012, Hepatobiliary & pancreatic diseases international : HBPD INT.

[103]  G. Michalopoulos,et al.  Collagenase pretreatment and the mitogenic effects of hepatocyte growth factor and transforming growth factor‐α in adult rat liver , 1994, Hepatology.

[104]  R. Chamuleau,et al.  Which Are the Right Cells to be Used in a Bioartificial Liver? , 2005, Metabolic Brain Disease.

[105]  C. Payne,et al.  Novel immortalized human fetal liver cell line, cBAL111, has the potential to differentiate into functional hepatocytes , 2009, BMC biotechnology.

[106]  C. Rescan,et al.  Growth control and cell cycle progression in cultured hepatocytes , 2000 .

[107]  C. Guguen-Guillouzo,et al.  Cyclin‐dependent kinase 1 plays a critical role in DNA replication control during rat liver regeneration , 2009, Hepatology.

[108]  S. Bacchetti,et al.  Definition of adenovirus type 5 functions involved in the induction of chromosomal aberrations in human cells. , 1990, The Journal of general virology.

[109]  J. Albrecht,et al.  Cell Cycle Control in the Liver , 2009 .

[110]  M. Ikeno,et al.  Treatment of nonalbumin rats by transplantation of immortalized hepatocytes using artificial human chromosome. , 2009, Transplantation proceedings.

[111]  M. Obinata,et al.  Hepatocyte cell lines established from transgenic mice harboring temperature-sensitive simian virus 40 large T-antigen gene. , 1991, Experimental cell research.

[112]  Shusen Zheng,et al.  Evaluation of a reversibly immortalized human hepatocyte line in bioartificial liver in pigs , 2012 .

[113]  M. Sakaguchi,et al.  Transplantation of reversibly immortalized insulin-secreting human hepatocytes controls diabetes in pancreatectomized pigs. , 2004, Diabetes.

[114]  R. Reddel,et al.  Comparison of human mammary epithelial cells immortalized by simian virus 40 T-Antigen or by the telomerase catalytic subunit , 2002, Oncogene.

[115]  Sangeeta N Bhatia,et al.  Improving the next generation of bioartificial liver devices. , 2002, Seminars in cell & developmental biology.

[116]  M. Kay,et al.  Hepatocyte transplantation: clinical and experimental application , 2001, Journal of Molecular Medicine.

[117]  M. Serra,et al.  Predictors of morbidity and mortality after the first episode of upper gastrointestinal bleeding in liver cirrhosis. , 2000, Journal of hepatology.

[118]  M. Oshimura,et al.  Telomerase-mediated life-span extension of human primary fibroblasts by human artificial chromosome (HAC) vector. , 2008, Biochemical and biophysical research communications.

[119]  R. Chamuleau,et al.  Recent Developments on Human Cell Lines for the Bioartificial Liver , 2002, The International journal of artificial organs.

[120]  E. Blackburn,et al.  Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[121]  敏範 都津川 Survival of liver failure pigs by transplantation of reversibly immortalized human hepatocytes with tamoxifen-mediated self-recombination , 2007 .

[122]  C. Lang,et al.  Interleukin-6 inhibits growth hormone-mediated gene expression in hepatocytes. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[123]  N. Kobayashi,et al.  Establishment of a reversibly immortalized human hepatocyte cell line by using Cre/loxP site-specific recombination. , 2000, Transplantation proceedings.

[124]  Masahiro Ito,et al.  Immortalized Hepatocytes Using Human Artificial Chromosome , 2008, Cell transplantation.

[125]  M. Kay,et al.  Fate tracing of mature hepatocytes in mouse liver homeostasis and regeneration. , 2011, The Journal of clinical investigation.

[126]  P. Leboulch,et al.  Reversible immortalization of mammalian cells mediated by retroviral transfer and site-specific recombination. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[127]  X. Chu,et al.  Comparison of Immortalized Fa2N-4 Cells and Human Hepatocytes as in Vitro Models for Cytochrome P450 Induction , 2008, Drug Metabolism and Disposition.

[128]  C. Guguen-Guillouzo,et al.  Transient expression of c-fos and constant expression of c-myc in freshly isolated and cultured normal adult rat hepatocytes. , 1988, Oncogene research.

[129]  M. Garrett,et al.  Phosphorylation of cyclin D1 at Thr 286 during S phase leads to its proteasomal degradation and allows efficient DNA synthesis , 2005, Oncogene.

[130]  D. Gilot,et al.  Regulation and role of p21 and p27 cyclin-dependent kinase inhibitors during hepatocyte differentiation and growth. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[131]  Jiaxin Bai,et al.  Construction of a Single Lentiviral Vector Containing Tetracycline-Inducible Alb-uPA for Transduction of uPA Expression in Murine Hepatocytes , 2013, PloS one.

[132]  G. Michalopoulos,et al.  Conditions for growth of hepatocytes in culture , 2000 .

[133]  G. Michalopoulos Liver regeneration after partial hepatectomy: critical analysis of mechanistic dilemmas. , 2010, The American journal of pathology.

[134]  Hanspeter Herzel,et al.  Regulation of mammalian cell cycle progression in the regenerating liver. , 2011, Journal of theoretical biology.

[135]  R. Whitehead,et al.  Conditionally immortalized mouse hepatocytes for use in liver gene therapy , 2000, Journal of gastroenterology and hepatology.

[136]  M. O'hare,et al.  Immortalization of human hepatocytes by temperature-sensitive SV40 large-T antigen , 2001, In Vitro Cellular & Developmental Biology - Animal.

[137]  J. Londoño-Vallejo,et al.  Impairment of the telomere/telomerase system and genomic instability are associated with keratinocyte immortalization induced by the skin human papillomavirus type 38 , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[138]  Joel N Meyer,et al.  Cellular toxicity associated with exposure to perfluorinated carboxylates (PFCAs) and their metabolic precursors. , 2014, Chemical research in toxicology.

[139]  R. Chamuleau,et al.  Proliferative human cell sources applied as biocomponent in bioartificial livers: a review , 2012, Expert opinion on biological therapy.

[140]  S. Bacchetti,et al.  Expression of SV40 large T antigen, but not small t antigen, is required for the induction of chromosomal aberrations in transformed human cells. , 1991, Virology.

[141]  Mitsuo Oshimura,et al.  Human artificial chromosomes for gene delivery and the development of animal models. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[142]  D. Jackson,et al.  Conditional enhancement of liver-specific gene transcription. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[143]  Lanjuan Li,et al.  Establishment and characterization of immortalized human hepatocyte cell line for applications in bioartificial livers , 2012, Biotechnology Letters.

[144]  M. Zern,et al.  In Vitro Expansion of Human Hepatocytes is Restricted by Telomere-Dependent Replicative Aging , 2003, Cell transplantation.

[145]  Jos H Beijnen,et al.  An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons. , 2003, Toxicology and applied pharmacology.

[146]  J. Roy-Chowdhury,et al.  A long‐term hepatitis B viremia model generated by transplanting nontumorigenic immortalized human hepatocytes in Rag‐2–deficient mice , 2000, Hepatology.

[147]  M. Sakaguchi,et al.  Reactivation of liver-specific gene expression in an immortalized human hepatocyte cell line by introduction of the human HNF4alpha2 gene. , 2001, International journal of molecular medicine.

[148]  J. Albrecht,et al.  Cyclin D1 promotes mitogen-independent cell cycle progression in hepatocytes. , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[149]  Andrei Seluanov,et al.  Coevolution of telomerase activity and body mass in mammals: From mice to beavers , 2009, Mechanisms of Ageing and Development.

[150]  M. T. Donato,et al.  Human hepatocytes in primary culture: the choice to investigate drug metabolism in man. , 2004, Current drug metabolism.

[151]  Lanjuan Li,et al.  Establishment of Highly Differentiated Immortalized Human Hepatocyte Line With Simian Virus 40 Large Tumor Antigen for Liver Based Cell Therapy , 2005, ASAIO journal.

[152]  Jonas Larsson,et al.  Intact signaling by transforming growth factor β is not required for termination of liver regeneration in mice , 2004, Hepatology.

[153]  G. Cooper The Cell: A Molecular Approach , 1996 .

[154]  M. Haas,et al.  Cell lines with heterogeneous phenotypes result from a single isolation of albumin‐sv40 T‐antigen transgenic rat hepatocytes , 1997, Hepatology.

[155]  Masahiro Ito,et al.  Treatment of liver failure in rats with end‐stage cirrhosis by transplantation of immortalized hepatocytes , 2002, Hepatology.

[156]  V. Krajka-Kuźniak,et al.  Xanthohumol induces phase II enzymes via Nrf2 in human hepatocytes in vitro. , 2013, Toxicology in vitro : an international journal published in association with BIBRA.

[157]  M. Sakaguchi,et al.  Expression of CYP3A4 by an immortalized human hepatocyte line in a three-dimensional culture using a radial-flow bioreactor. , 2004, International journal of molecular medicine.

[158]  C. Lee,et al.  FAT10, an ubiquitin-like protein, confers malignant properties in non-tumorigenic and tumorigenic cells. , 2014, Carcinogenesis.

[159]  M. Barbacid,et al.  Mammalian cyclin-dependent kinases. , 2005, Trends in biochemical sciences.

[160]  F. Paillard Reversible cell immortalization with the Cre-lox system. , 1999, Human gene therapy.

[161]  K. Meyer,et al.  Hepatitis C virus core protein promotes immortalization of primary human hepatocytes. , 2000, Virology.

[162]  S. Dong,et al.  Temporary amelioration of bilirubin conjugation defect in Gunn rats by transplanting conditionally immortalized hepatocytes , 2002, Journal of gastroenterology and hepatology.

[163]  J. Fassett,et al.  Differential regulation of cyclins D1 and D3 in hepatocyte proliferation , 2002, Hepatology.

[164]  G. Babcock,et al.  Liver-specific pRB loss results in ectopic cell cycle entry and aberrant ploidy. , 2005, Cancer research.

[165]  T. Brümmendorf,et al.  Absence of oncogenic transformation despite acquisition of cytogenetic aberrations in long-term cultured telomerase-immortalized human fetal hepatocytes. , 2007, Cancer letters.

[166]  C D Woodworth,et al.  Transformation of differentiated rat hepatocytes with adenovirus and adenovirus DNA , 1987, Journal of virology.

[167]  S. Dong,et al.  Dedifferentiation of conditionally immortalized hepatocytes with long-term in vitro passage , 2000, Experimental & Molecular Medicine.

[168]  T. Seki,et al.  Role of p16(INK4a) in the inhibition of DNA synthesis stimulated by HGF or EGF in primary cultured rat hepatocytes. , 2013, Biomedical research.

[169]  N. Chowdhury,et al.  Treatment of surgically induced acute liver failure by transplantation of conditionally immortalized hepatocytes. , 1997, Transplantation.

[170]  R. Taub Liver regeneration: from myth to mechanism , 2004, Nature Reviews Molecular Cell Biology.

[171]  C. Guha,et al.  Reversibly immortalized human hepatocytes: An eternal fountain of liver support? , 2000 .

[172]  N. Kobayashi,et al.  Construction of a non-tumorigenic rat hepatocyte cell line for transplantation: reversal of hepatocyte immortalization by site-specific excision of the SV40 T antigen. , 2000, Journal of Hepatology.

[173]  M. Sakaguchi,et al.  Transduction of Immortalized Human Hepatocytes with p21 to Enhance Differentiated Phenotypes , 2002, Cell transplantation.

[174]  D. Gilot,et al.  Multiple division cycles and long‐term survival of hepatocytes are distinctly regulated by extracellular signal‐regulated kinases ERK1 and ERK2 , 2009, Hepatology.

[175]  P. Klenerman,et al.  Liver cell lines for the study of hepatocyte functions and immunological response , 2005, Liver international : official journal of the International Association for the Study of the Liver.

[176]  S. Yoshida,et al.  Up-regulation of telomerase in primary cultured rat hepatocytes. , 1999, Journal of biochemistry.

[177]  R. Schlegel,et al.  Disregulation of mitotic checkpoints and regulatory proteins following acute expression of SV40 large T antigen in diploid human cells , 1997, Oncogene.

[178]  J. Lehmann,et al.  Cultivation and Characterization of a New Immortalized Human Hepatocyte Cell Line, HepZ, for Use in an Artificial Liver Support System , 1999, Annals of the New York Academy of Sciences.

[179]  Jane R Kenny,et al.  Evaluation of Multiple in Vitro Systems for Assessment of CYP3A4 Induction in Drug Discovery: Human Hepatocytes, Pregnane X Receptor Reporter Gene, and Fa2N-4 and HepaRG Cells , 2009, Drug Metabolism and Disposition.